VILLA MED CTR
1-2 ROMAN ROAD, PRENTON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 12 | 16 | 75.0% | |
| HF 4 | 2011 | 15 | 21 | 71.4% | |
| HF 4 | 2012 | 16 | 20 | 80.0% | |
| HF 4 | 2013 | 17 | 17 | 100.0% | |
| HF004 | 2014 | 8 | 9 | 88.9% | |
| HF004 | 2015 | 6 | 7 | 85.7% | |
| HF004 | 2016 | 21 | 21 | 100.0% | |
| HF004 | 2017 | 21 | 21 | 100.0% | |
| HF004 | 2018 | 31 | 34 | 91.2% | |
| HF004 | 2019 | 34 | 39 | 87.2% | |
| HF004 | 2020 | 39 | 42 | 92.9% | |
| HF006 | 2021 | 49 | 51 | 96.1% | |
| HF006 | 2022 | 43 | 43 | 100.0% | |
| HF006 | 2023 | 51 | 52 | 98.1% |
